看多
Idea about Aerie Pharmaceuticals
Aerie Pharmaceuticals is a pharmaceutical company dedicated to developing treatments for glaucoma and other eye conditions. Founded in 2005. Revenue $ 83 million (2020). Capitalization $ 489 million
Medium-term trade following a trend. The low of the candlestick at $ 9.68 formed a support level upon a repeated approach to the base of the trend reversal.
The reference point for the target is the level formed by the maximum of the trend reversal candle of the previous local maximum.
Long $ 10.28
Goal: $ 12.1
Stop below $ 9.9
NOT IRR.
Medium-term trade following a trend. The low of the candlestick at $ 9.68 formed a support level upon a repeated approach to the base of the trend reversal.
The reference point for the target is the level formed by the maximum of the trend reversal candle of the previous local maximum.
Long $ 10.28
Goal: $ 12.1
Stop below $ 9.9
NOT IRR.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。